Mycophenolate Mofetil Ameliorates Diabetic Nephropathy Through Epithelial Mesenchymal Transition in Rats

Molecular Medicine Reports - Greece
doi 10.3892/mmr.2015.3934
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Carvedilol Ameliorates Early Diabetic Nephropathy in Streptozotocin-Induced Diabetic Rats

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2014English

C3a Mediates Epithelial-To-Mesenchymal Transition in Proteinuric Nephropathy

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2009English

Resveratrol Ameliorates Diabetic Nephropathy in Rats Through Negative Regulation of the P38 MAPK/TGF-β1 Pathway

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2017English

MicroRNA-130b Improves Renal Tubulointerstitial Fibrosis via Repression of Snail-Induced Epithelial-Mesenchymal Transition in Diabetic Nephropathy

Scientific Reports
Multidisciplinary
2016English

Long Noncoding RNA ENSRNOG00000037522 Is Involved in the Podocyte Epithelial‑mesenchymal Transition in Diabetic Rats

International Journal of Molecular Medicine
MedicineGenetics
2018English

Lipoxin A4 Ameliorates Lipopolysaccharide-Induced Lung Injury Through Stimulating Epithelial Proliferation, Reducing Epithelial Cell Apoptosis and Inhibits Epithelial–mesenchymal Transition

Respiratory Research
PulmonaryRespiratory Medicine
2019English

Mp67-15 Antifibrotic Effect of Mycophenolate Mofetil in Rats With Peyronie's Disease

Journal of Urology
Urology
2018English

SIX1 Promotes Epithelial–mesenchymal Transition in Colorectal Cancer Through ZEB1 Activation

Oncogene
Cancer ResearchGeneticsMolecular Biology
2012English

Spironolactone Prevents Diabetic Nephropathy Through an Anti-Inflammatory Mechanism in Type 2 Diabetic Rats

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy